Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_assertion type Assertion NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_head.
- NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_assertion wasGeneratedBy ECO_0000203 NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_provenance.
- NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_assertion wasDerivedFrom befree-2016 NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_provenance.
- NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_assertion SIO_000772 21349946 NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_provenance.
- NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_assertion evidence source_evidence_literature NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_provenance.
- NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_assertion description "[Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875003.RAwa1D5OzwcvTZVL01oQVtQRDIRFu4jb3Q5KZXjZnm1r0130_provenance.